PortfoliosLab logoPortfoliosLab logo
New1
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


SBER.ME 30.00%PLZL.ME 30.00%BSPB.ME 20.00%MDMG.ME 20.00%EquityEquity

S&P 500 Index

Portfolio Optimizer

Find the right asset allocation for New1

Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in New1, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every month.


Loading charts...

Returns By Period


Position1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.50%-0.93%8.56%8.85%24.33%19.37%11.84%13.61%
Portfolio
New1
0.51%-2.93%6.62%11.26%33.08%21.65%11.95%
BSPB.ME
"Bank "Saint-Petersburg" Public Joint-Stock Company
0.43%-7.56%11.52%7.70%0.69%44.41%50.92%27.61%
MDMG.ME
MD Medical Group Investments Plc
-0.79%-2.80%-7.06%3.65%49.79%34.67%13.50%
PLZL.ME
Public Joint Stock Company Polyus
2.29%-3.94%-5.89%2.99%36.46%-36.96%-31.23%-5.65%
SBER.ME
Sberbank of Russia
-0.23%0.45%26.45%25.66%36.04%22.91%4.62%12.28%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Nov 9, 2020, New1's average daily return is +0.09%, while the average monthly return is +1.91%. At this rate, an investment would double in approximately 3.1 years.

Historically, 65% of months were positive and 35% were negative. The best month was Mar 2022 with a return of +23.0%, while the worst month was Feb 2022 at -37.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.

On a daily basis, New1 closed higher 51% of trading days. The best single day was Mar 30, 2022 with a return of +11.9%, while the worst single day was Feb 24, 2022 at -31.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20268.85%-1.29%-11.09%8.35%7.11%-3.82%6.62%
202523.03%-14.80%7.58%-0.35%4.73%3.27%3.99%4.83%-3.87%1.45%7.87%2.75%43.19%
202411.31%2.03%3.15%7.43%2.59%4.30%0.19%-14.01%7.14%-7.96%-10.35%5.70%8.42%
202318.77%-5.49%16.45%7.92%1.13%-6.45%11.86%6.98%-3.98%2.44%-0.72%-0.97%54.43%
2022-11.33%-37.01%23.04%4.80%6.16%12.47%-6.50%5.99%-24.43%18.48%9.09%-15.25%-29.45%
2021-4.19%4.90%3.74%5.97%13.11%-1.50%0.24%5.79%-1.48%14.26%-8.64%-7.16%24.66%

Benchmark Metrics

New1 has an annualized alpha of 24.05%, beta of 0.27, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since November 09, 2020.

  • This portfolio captured 113.67% of S&P 500 Index gains but only 92.64% of its losses - a favorable profile for investors.
  • Beta of 0.27 may look defensive, but with R2 of 0.02 this portfolio is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
  • R2 of 0.02 means this portfolio moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
24.05%
Beta
0.27
0.02
Upside Capture
113.67%
Downside Capture
92.64%

Expense Ratio

New1 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

New1 ranks 24 for risk / return — below 24% of Portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


New1 Risk / Return Rank: 2424
Overall Rank
New1 Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
New1 Sortino Ratio Rank: 2424
Sortino Ratio Rank
New1 Omega Ratio Rank: 1919
Omega Ratio Rank
New1 Calmar Ratio Rank: 2727
Calmar Ratio Rank
New1 Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below presents risk-adjusted performance metrics for New1 and compares them with S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PortfolioBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

1.44

1.86

-0.42

Sortino ratioReturn per unit of downside risk

2.05

2.53

-0.48

Omega ratioGain probability vs. loss probability

1.23

1.34

-0.11

Calmar ratioReturn relative to maximum drawdown

2.10

2.53

-0.43

Martin ratioReturn relative to average drawdown

6.68

11.37

-4.69


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

PositionRisk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
BSPB.ME
"Bank "Saint-Petersburg" Public Joint-Stock Company
40
0.030.241.030.030.06
MDMG.ME
MD Medical Group Investments Plc
82
1.732.321.252.787.80
PLZL.ME
Public Joint Stock Company Polyus
70
1.131.661.191.443.40
SBER.ME
Sberbank of Russia
81
1.492.251.252.687.27

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

The current New1 Sharpe ratio is 1.44 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.54 to 2.41, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of New1 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading charts...

Dividends

Dividend yield

New1 provided a 11.37% dividend yield over the last twelve months.


PositionTTM20252024202320222021202020192018201720162015
Portfolio11.37%9.29%3.82%4.03%2.30%2.81%2.41%4.50%4.23%2.86%0.65%1.07%
BSPB.ME
"Bank "Saint-Petersburg" Public Joint-Stock Company
14.83%15.01%13.71%18.78%11.47%5.60%6.24%6.59%3.76%1.90%1.57%4.71%
MDMG.ME
MD Medical Group Investments Plc
3.27%2.76%2.22%0.00%0.03%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PLZL.ME
Public Joint Stock Company Polyus
8.20%7.50%0.93%0.00%0.00%5.00%3.18%4.32%5.16%5.59%0.00%0.00%
SBER.ME
Sberbank of Russia
17.62%11.62%1.19%0.92%0.00%0.64%0.69%6.28%6.43%2.66%1.14%0.44%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the New1. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the New1 was 59.91%, occurring on Mar 25, 2022. Recovery took 472 trading sessions.

The current New1 drawdown is 6.86%.


Related event

Drawdown

Fall

Recovery

Underwater

Bear market2022
-59.91%Mar 2022
4mo 13d1y 10mo
2y 2moNov 2021 - Feb 2024
2024 bear market2024
-32.11%Nov 2024
6mo 9d2mo 15d
8mo 24dMay 2024 - Feb 2025
2025 selloff2025
-29.93%Apr 2025
1mo 22d9mo 10d
11mo 2dFeb 2025 - Jan 2026
2026 correction2026
-17.29%Mar 2026
1mo 22d2mo 1d
3mo 23dJan 2026 - May 2026
2021 pullback2021
-9.35%Jan 2021
8d1mo 15d
1mo 23dJan 2021 - Mar 2021

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 4 assets, with an effective number of assets of 3.85, reflecting the diversification based on asset allocation. Your capital is spread almost evenly across your holdings, indicating a well-balanced allocation. Note that true diversification also depends on the correlations between assets — check the diversification ratio below.


Diversification Ratio
1Y
3Y
5Y
All Time
Diversification Ratio

1.23

1.35

1.31

1.32

The portfolio has a diversification ratio of 1.32, in line with the typical range across portfolios. There's room to improve by adding less correlated assets.

New1 correlation to the S&P 500 Index

New1 has a 0.21 correlation to S&P 500 Index over the trailing 12 months. This section compares each holding's correlation to the benchmark and to the portfolio.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Nov 9, 2020

0.16


Benchmark Correlations

Correlation vs. S&P 500 Index. SBER.ME has the highest benchmark correlation at 0.15, while BSPB.ME has the lowest at 0.09.

Portfolio Correlations

Correlation vs. New1. SBER.ME has the highest portfolio correlation at 0.82, while MDMG.ME has the lowest at 0.72.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

PLZL.MEMDMG.MEBSPB.MESBER.ME
PLZL.ME1.000.430.440.51
MDMG.ME0.431.000.500.53
BSPB.ME0.440.501.000.60
SBER.ME0.510.530.601.00
The correlation results are calculated based on daily price changes starting from Nov 9, 2020
Diversification Analysis

Find what New1 is missing

See which holdings overlap, where New1 is concentrated, and which low-correlation assets could fill the gaps.

Analyze Diversification